Hypoxia-induced fibroblast growth factor 11 stimulates capillary-like endothelial tube formation

Oncology Reports

Volumn 34, Issue 5, 2015, Pages 2745-2751

  Yang, Jimin ^a   Kim, Woo Jean ^b   Jun, Hyoung Oh ^a   Lee, Eun Ju ^a   Lee, Kyeong Won ^c   Jeong, Jae Yeon ^c   Lee, Sae Won ^a  

^a Seoul National University Biomedical Research Institute   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Korea Research Institute of Ships and Ocean Engineering   (South Korea)

Author keywords

Fibroblast growth factor 11; Growth factor; Hypoxia response element; Hypoxia inducible factor 1; Transcription factor; Tumor angiogenesis

Indexed keywords

CLAUDIN 5; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 11; HYPOXIA INDUCIBLE FACTOR 1; LUCIFERASE; OCCLUDIN; PROTEIN ZO1; UNCLASSIFIED DRUG; CLDN5 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 11, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TJP1 PROTEIN, HUMAN;

ARTICLE; CAPILLARY; CELL MIGRATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GENE ACTIVITY; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIA RESPONSE ELEMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REPORTER GENE; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; BINDING SITE; CELL HYPOXIA; CELL MOTION; CHEMISTRY; CYTOLOGY; ENDOTHELIUM CELL; GENETICS; HEK293 CELL LINE; METABOLISM; UPREGULATION;

BINDING SITES; CELL HYPOXIA; CELL MOVEMENT; CLAUDIN-5; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTORS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROMOTER REGIONS, GENETIC; UP-REGULATION; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84941953339     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4223     Document Type: Article

References (32)

1. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
2. Lee SW, Jeong HK, Lee JY, Yang J, Lee EJ, Kim SY, Youn SW, Lee J, Kim WJ, Kim KW, et al: Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGF. EMBO Mol Med 4: 924-938, 2012.
3. Lee SW, Yang J, Kim SY, Jeong HK, Lee J, Kim WJ, Lee EJ and Kim HS: MicroRNA-26a induced by hypoxia targets HDAC6 in myogenic differentiation of embryonic stem cells. Nucleic Acids Res 43: 2057-2073, 2015.
4. Lee SW, Lee YM, Bae SK, Murakami S, Yun Y and Kim KW: Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem Biophys Res Commun 268: 456-461, 2000.
5. Lee SW, Won JY, Kim WJ, Lee J, Kim KH, Youn SW, Kim JY, Lee EJ, Kim YJ, Kim KW, et al: Snail as a potential target molecule in cardiac fibrosis: Paracrine action of endothelial cells on fibroblasts through snail and CTGF axis. Mol Ther 21: 1767-1777, 2013.
6. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998.
7. M oulder JE and Rockwell S: Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695-712, 1984.
8. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
9. Holash J, Wiegand SJ and Yancopoulos GD: New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362, 1999.
10. Dimmeler S and Zeiher AM: Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87: 434-439, 2000.
11. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
12. Folkman J: Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
13. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999.
14. Friesel RE and Maciag T: Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J 9: 919-925, 1995.
15. Yotsumoto F, Tokunaga E, Oki E, Maehara Y, Yamada H, Nakajima K, Nam SO, Miyata K, Koyanagi M, Doi K, et al: Molecular hierarchy of heparin-binding EGF-like growth factorregulated angiogenesis in triple-negative breast cancer. Mol Cancer Res 11: 506-517, 2013.
16. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
17. Itoh N and Ornitz DM: Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237: 18-27, 2008.
18. Itoh N and Ornitz DM: Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease. J Biochem 149: 121-130, 2011.
19. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ and Kim KW: SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9: 900-906, 2003.
20. Lee SW, Jung KH, Jeong CH, Seo JH, Yoon DK, Suh JK, Kim KW and Kim WJ: Inhibition of endothelial cell migration through the down-regulation of MM P-9 by A-kinase anchoring protein 12. Mol Med Rep 4: 145-149, 2011.
21. Runkle EA and Mu D: Tight junction proteins: From barrier to tumorigenesis. Cancer Lett 337: 41-48, 2013.
22. Ding I, Liu W, Sun J, Fenton B and Okunieff P: Comparison and modulation of angiogenic responses by FGFs, VEGF and SCF in murine and human fibrosarcomas. Comp Biochem Physiol A Mol Integr Physiol 132: 17-25, 2002.
23. Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J and Chang C: Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MM P9 signaling. Mol Oncol 9: 44-57, 2015.
24. Zhuang Z, Jian P, Longjiang L, Bo H and Wenlin X: Oral cancer cells with different potential of lymphatic metastasis displayed distinct biologic behaviors and gene expression profiles. J Oral Pathol Med 39: 168-175, 2010.
25. Lee SW, Kim WJ, Jun HO, Choi YK and Kim KW: Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2. Int J Mol Med 23: 279-284, 2009.
26. Brennan K, Offiah G, McSherry EA and Hopkins AM: Tight junctions: A barrier to the initiation and progression of breast cancer? J Biomed Biotechnol 2010: 460607, 2010.
27. Bouchagier KA, Assimakopoulos SF, Karavias DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D, Scopa CD and Tsamandas AC: Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival. In Vivo 28: 315-326, 2014.
28. Nissi R, Talvensaari-Mattila A, Kuvaja P, Pääkkö P, Soini Y and Santala M: Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors. Anticancer Res 35: 973-976, 2015.
29. Soini Y, Eskelinen M, Juvonen P, Kärjä V, Haapasaari KM, Saarela A and Karihtala P: Strong claudin 5 expression is a poor prognostic sign in pancreatic adenocarcinoma. Tumour Biol 35: 3803-3808, 2014.
30. Sugimoto H, Nagahara M, Bae Y, Nakagawa T, Ishikawa T, Sato T, Uetake H, Eishi Y and Sugihara K: Clinicopathologic relevance of claudin 5 expression in breast cancer. Am J Clin Pathol 143: 540-546, 2015.
31. Kleeff J, Shi X, Bode HP, Hoover K, Shrikhande S, Bryant PJ, Korc M, Büchler MW and Friess H: Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer. Pancreas 23: 259-265, 2001.
32. Yang Y, Sun M, Wang L and Jiao B: HIFs, angiogenesis, and cancer. J Cell Biochem 114: 967-974, 2013.